Correlation Between Eli Lilly and Daiichi Sankyo
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Daiichi Sankyo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Daiichi Sankyo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Daiichi Sankyo Co, you can compare the effects of market volatilities on Eli Lilly and Daiichi Sankyo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Daiichi Sankyo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Daiichi Sankyo.
Diversification Opportunities for Eli Lilly and Daiichi Sankyo
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eli and Daiichi is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Daiichi Sankyo Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daiichi Sankyo and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Daiichi Sankyo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daiichi Sankyo has no effect on the direction of Eli Lilly i.e., Eli Lilly and Daiichi Sankyo go up and down completely randomly.
Pair Corralation between Eli Lilly and Daiichi Sankyo
Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.85 times more return on investment than Daiichi Sankyo. However, Eli Lilly and is 1.18 times less risky than Daiichi Sankyo. It trades about 0.1 of its potential returns per unit of risk. Daiichi Sankyo Co is currently generating about 0.01 per unit of risk. If you would invest 35,515 in Eli Lilly and on August 30, 2024 and sell it today you would earn a total of 43,304 from holding Eli Lilly and or generate 121.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eli Lilly and vs. Daiichi Sankyo Co
Performance |
| Timeline |
| Eli Lilly |
| Daiichi Sankyo |
Eli Lilly and Daiichi Sankyo Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eli Lilly and Daiichi Sankyo
The main advantage of trading using opposite Eli Lilly and Daiichi Sankyo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Daiichi Sankyo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daiichi Sankyo will offset losses from the drop in Daiichi Sankyo's long position.| Eli Lilly vs. Johnson Johnson | Eli Lilly vs. Bristol Myers Squibb | Eli Lilly vs. AbbVie Inc | Eli Lilly vs. Pfizer Inc |
| Daiichi Sankyo vs. Astellas Pharma | Daiichi Sankyo vs. Grifols SA ADR | Daiichi Sankyo vs. Roche Holding Ltd | Daiichi Sankyo vs. Novartis AG ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |